Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,383,646
-$125,570 QoQ
Shares Held
7,264
-8.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#980
of 2,092 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DoubleLine ETF Adviser LP holds $6,174,343 across 9 Diagnostics & Research names. DHR ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,270 | $2,140,807 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
7,264 | $1,383,646 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
865 | $455,370 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
2,268 | $438,222 | |
| 5 | A |
Agilent Technologies, Inc.
|
3,098 | $411,507 | |
| 6 | WAT |
Waters Corp /De/
|
1,070 | $401,292 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,545 | $327,462 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,169 | $327,320 |
All Filings in DHR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,383,646 | 7,264 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,509,216 | 7,960 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||